PROLARYN GEL 8602M0K5

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2016-06-16 for PROLARYN GEL 8602M0K5 manufactured by Merz North America, Inc..

Event Text Entries

[47502389] This case was assessed as reportable to the fda as the adverse event, possible allergic reaction requiring intubation, was deemed to meet serious injury criteria of requiring medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure. The device history record for radiesse dermal filler lot 100088620 was reviewed. No nonconformances were noted that would have contributed to this event. A lot search was conducted on the reported lot and no similar events were noted.
Patient Sequence No: 1, Text Type: N, H10


[47502390] A physician reported that a (b)(6) male patient was injected with prolaryn. On (b)(6) 2016, patient was injected with an unspecified amount of prolaryn to an unspecified area. On (b)(6) 2016, patient developed increased breathing, a fever of 102, and voice changes. Treatment reported as intubation. On 24-may-2016, follow up information was received from the physician. Patient had no vocal fold paresis, paralysis, or atrophy. Patient was injected to the interarytenoid space with an unspecified amount of prolaryn gel for dysphagia. On 06-jun-2016, follow up information was received from the physician. Patient was injected with 0. 3ml of prolaryn gel and experienced a possible allergic reaction. On an unspecified date, patient was intubated to protect the airway. Five days later, he was extubated. Medical history positive for chronic dysphagia and aspiration. Concomitant medications and relevant medical history reported as none. Lot number reported as 100088620. Causality reported as possibly related.
Patient Sequence No: 1, Text Type: D, B5


[49802987] The device history record for prolaryn gel lot 100088620 was reviewed.
Patient Sequence No: 1, Text Type: N, H10


[49802988] The following information was gathered from medwatch report mw5062519, which was received on 06-jul-2016. The patient developed respiratory distress requiring intubation 24 hours following injection with prolaryn gel to the interarytenoid space. Patient was intubated for four days and eventually extubated without complication. The route of administration was submucous. The indication for use was pharyngeal dysplasia.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2135225-2016-00015
MDR Report Key5728789
Report SourceHEALTH PROFESSIONAL
Date Received2016-06-16
Date of Report2016-07-06
Date of Event2016-05-19
Date Mfgr Received2016-07-06
Device Manufacturer Date2016-03-15
Date Added to Maude2016-06-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSCOTT SYKES, MD
Manufacturer Street6501 SIX FORKS ROAD
Manufacturer CityRALEIGH NC 27615
Manufacturer CountryUS
Manufacturer Postal27615
Manufacturer Phone9195828000
Manufacturer G1MERZ NORTH AMERICA, INC.
Manufacturer Street4133 COURTNEY ROAD SUITE 10
Manufacturer CityFRANKSVILLE WI 53126
Manufacturer CountryUS
Manufacturer Postal Code53126
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePROLARYN GEL
Generic NameINJECTABLE IMPLANT
Product CodeMIX
Date Received2016-06-16
Catalog Number8602M0K5
Lot Number100088620
Device Expiration Date2017-03-15
OperatorPHYSICIAN
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerMERZ NORTH AMERICA, INC.
Manufacturer Address4133 COURTNEY STREET, SUITE 10 FRANKSVILLE WI 53126 US 53126


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2016-06-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.